Reaction
Intra-Abdominal Haematoma reporting signals
As of the last recalculation, Intra-Abdominal Haematoma appears in 1,227 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is FONDAPARINUX SODIUM (PRR 141.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fondaparinux Sodium | 64 | 141.5 | 142.6 |
| Enoxaparin Sodium | 153 | 51.4 | 51.5 |
| Dalteparin Sodium | 18 | 29.3 | 29.3 |
| Warfarin Sodium | 60 | 23.0 | 23.0 |
| Basiliximab | 14 | 20.4 | 20.4 |
| Warfarin | 135 | 20.1 | 20.2 |
| Heparin Sodium | 14 | 17.5 | 17.5 |
| Goserelin | 11 | 14.0 | 14.0 |
| Valganciclovir Hydrochloride Powder, | 10 | 14.0 | 14.0 |
| Valganciclovir | 15 | 13.7 | 13.7 |
| Valganciclovir Hydrochloride | 15 | 13.7 | 13.7 |
| Febuxostat Tablets 40 Mg | 7 | 11.7 | 11.7 |
| Febuxostat Tablets 80 Mg | 7 | 11.7 | 11.7 |
| Dronedarone | 7 | 11.7 | 11.7 |
| Rivaroxaban | 125 | 11.2 | 11.2 |
| Nebivolol | 10 | 10.7 | 10.7 |
| Prasugrel Hydrochloride | 6 | 10.1 | 10.1 |
| Emicizumab | 5 | 6.9 | 6.9 |
| Dabigatran Etexilate | 27 | 6.0 | 6.0 |
| Sevelamer Carbonate | 4 | 5.9 | 5.9 |
| Dabigatran Etexilate Mesylate | 24 | 5.7 | 5.7 |
| Atezolizumab | 11 | 4.8 | 4.8 |